Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUCOVID: Mucosal Immunity in COVID-19
NCT06142279Unknown
- Sponsor
- University Hospital Tours
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by University Hospital Tours. Primary endpoints: Anti-Spike mucosal humoral immune response (Secretory IgA in nasal secretions) at Day 0 and Neutralizing capacity of anti-Spike IgA in nasal secretions at Day 0. Status: unknown.
Beyond the preview
Go deeper on NCT06142279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06142279.